ArticleScientific reports2021
The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas.
Kai Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it